ABN Amro Investment Solutions Trims Stock Position in Intuitive Surgical, Inc. $ISRG

ABN Amro Investment Solutions cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 49.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,727 shares of the medical equipment provider’s stock after selling 9,336 shares during the period. ABN Amro Investment Solutions’ holdings in Intuitive Surgical were worth $4,350,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rossmore Private Capital lifted its position in Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after buying an additional 20 shares during the last quarter. Activest Wealth Management raised its stake in shares of Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after acquiring an additional 20 shares during the period. Vertex Planning Partners LLC lifted its holdings in shares of Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after acquiring an additional 21 shares during the last quarter. Accredited Investors Inc. boosted its position in shares of Intuitive Surgical by 2.0% during the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after purchasing an additional 21 shares during the period. Finally, SPC Financial Inc. boosted its position in shares of Intuitive Surgical by 1.3% during the 3rd quarter. SPC Financial Inc. now owns 1,614 shares of the medical equipment provider’s stock worth $722,000 after purchasing an additional 21 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on ISRG shares. UBS Group reissued a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. The Goldman Sachs Group reiterated a “buy” rating and issued a $714.00 price objective on shares of Intuitive Surgical in a report on Friday, January 9th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Raymond James Financial lifted their target price on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. Finally, Evercore cut their price target on shares of Intuitive Surgical from $580.00 to $550.00 and set an “in-line” rating on the stock in a research note on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Stock Up 1.5%

NASDAQ ISRG opened at $485.84 on Monday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $609.08. The firm has a 50 day moving average of $541.62 and a two-hundred day moving average of $510.40. The stock has a market capitalization of $172.54 billion, a PE ratio of 61.58, a price-to-earnings-growth ratio of 3.76 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The business had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue was up 18.8% on a year-over-year basis. During the same period last year, the business earned $2.21 EPS. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, VP Fredrik Widman sold 133 shares of the stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Myriam Curet sold 421 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total value of $208,378.16. Following the sale, the executive vice president directly owned 409 shares in the company, valued at $202,438.64. This trade represents a 50.72% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 56,189 shares of company stock valued at $30,785,441. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.